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  Hypertension  - Essential Hypertension  
  BP    -  Blood pressure  
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  gms   - Grams  
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  LNE   - Lymphnode Enlargement  
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  MAP   - Mean Arterial Pressure     
  RAS   - Renin Angiotensin System  
  SBP   - Systolic Blood Pressure  
  SD   - Standard Deviation 
  TOD   -  Target Organ Damage 
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INTRODUCTION 
 
 Hypertension is widespread in the community and is the major 
contributing factor for cardiovascular morbidity and mortality. To add to this it 
also shows its evil paw to nearly every organ in the body.  
History  
   Target organ damage and hypertension has been dealt by western authors 
as early as 1800’s and vast review of literature has been published in the west. 
In sharp contrast blood pressure and target organ damage had been dealt by 
Charaka even before the birth of Christ when he had given Raulfina Serpitina 
for his patients who suffered from hypertension, but we still lack good literature 
of the prevalence and the impact of target organ damage in newly detected 
hypertensives to our dear society.  
Euro American views of target organ damage in hypertension  
 The Joint National Committee (JNC)1 VII states that not to search for 
target organ damage as an essential procedure in the diagnostic approach of the 
high blood pressure state, but the European guidelines given by the European 
Society of hypertension2 suggests that searching for target organ damage is of 
  
crucial importance for stratifying the cardiovascular risk of the hypertensive 
population.  
 
Indian population and hypertension  
 The Indian population is not well informed about health and illness. 
When a patient comes to the hospital for some other complaint and is diagnosed 
to have hypertension, the first response by the patient is to deny. The various 
stages involved in the treatment of hypertension is furnished below:  
 
 
 
 
 
 
 
 
Hypothesis / Assumptions  
 Most of the Indian patients come to a doctor of modern medicine only 
when the symptoms are likely to cause him distress in his routine activities or if 
these symptoms did not improve by other systems of medicine. So, there is a 
higher probability that our patient would have target organ damage at 
Hypertension conveyed 
to the patient 
Denial (pt not willing for full blown 
check up for his health status)  
Acceptance 
Patient accepts he has hypertension but refuses to take drugs due to 
the absence of symptoms  
Appearance of symptoms Patient accepts to take 
the drugs 
Maintenance phase 
and follow up. 
Education, support systems, 
family pressure   
Choosing alternative 
medicine 
  
presentation. Moreover there are no published reports available on covert target 
organ damage in newly detected hypertensive population and their possible 
association, so this study was undertaken.  
AIMS 
 
 
 
 
 
1. To find out the prevalence of Target organ damage in non alcoholic, 
non smoker, non obese, non dyslipidemic, newly detected rural 
essential hypertensives.  
 
2. To identify the pattern of Target organ damage. 
 
3. To analyse the gender difference.  
 
4. To assess the interrelationship between Target organ damage.     
 
 
 
 
 
  
 
 
 
REVIEW OF LITERATURE 
 
HISTORY 
Introduction  
 Blood pressure was measured for the first time by Stephen Hales in 1773 
along with which he described the importance of blood volume in blood 
pressure regulation3.  
 
Sphygmomanometer and blood pressure recording  
 Riva Rocci in1896 had invented the inflatable cuff sphygmomanometer 
that we use even today for the measurement of brachial systolic pressure; while 
Korotkoff in 1904 described the auscultatory method along with Korotkoff 
sounds to find out the diastolic pressure4.  
 
Pathogenesis  
 While going into the pathogenesis the contribution of the peripheral 
arterioles in maintaining the blood pressure was described by Lower in 1669 
and subsequently by Senae in 1783.  
  
 The role of vasomotor nerves in hypertension was represented in a 
monograph by William Dayliss in 19233.  
 
 
Target organ damage and Hypertension 
 Sir William Cull and H.G. Sutton (1872) described the cardiovascular 
changes in hypertension. Richard Bright in the first half of the 19th century 
observed the changes of hypertension on the cardiovascular system in chronic 
renal failure.  
 Irwin, Page, Gold Blatt in the later 19th century worked extensively on 
the biochemical basis of hypertension from which we have derived our 
concepts of systemic hypertension3.  
 Gower in 1870 was the first person who described arteriolar 
vasoconstriction in the retina in cases of elevated blood pressure using an 
ophthalmoscope4.  
 
Others  
 Fredrick Mahamood was the one who incorporated blood pressure 
measurement as a part of clinical evaluation3.  
 Frank in 1911 suggested the term essential hypertension in patients in 
whom no obvious cause of hypertension could be found out4.  
  
 
 
 
 
 
Table 1: Historical events in hypertension in chronological order 
          Year      Event  
 1669   Contribution of peripheral arterioles in maintaining  
    blood pressure – by Lower.  
 1773   Blood pressure was measured for the first time by  
    Stephen Hales     
 1870   Ocular changes in hypertension by Gower 
 1872   Cardiovascular changes in hypertension by  
    Sir William Cull and H.G. Sutton 
 1896   Riva Rocci invented the inflatable cuff  
  sphygmomanometer  
1904 Korotkoff described the ausculatatory sounds – 
measurement of diastolic blood pressure 
1911 The term essential hypertension coined by Frank 
1923 The role of vasomotor nerves in hypertension 
represented in a monograph by William Dayliss 
  
First half   Hypertension and CVS in patients with CRF 
19th century  Richard Bright   
Late 19th century Biochemical work on hypertension by Gold Blatt 
  Irwin, Page, Van Slyke. 
 
Prevalence  
 The prevalence of hypertension depends on both racial composition and 
the criteria used to define the condition and the varying prevalence may be due 
to the various cutoff values used. For an example.  
• Bechgard 19465 suggested a value of 160/100 mmHg 
• While Perala 1948 suggested a value of 140/90 mmHg  
• And Evans 1956 suggested 180/110 as a cutoff value for demarcating 
normotension from hypertension.    
• The Joint National Committee1 was formed in the United States to define 
hypertension, review it and to give new criteria and guidelines for 
treatment as newer advances occurred in the field. Most of the people in 
the world follow the JNC VII guidelines which was circulated in 2003. 
Europe follows its own guidelines as suggested by European society of 
Hypertension.  
 
  
In the Framingham study in a sub-urban population almost one half had 
hypertension as the pressures were greater than 140/90.  
The National heath and nutrition examination surveys in the US reported 
that the prevalence of hypertension was about 20% in the US population in 
19916.  
In India, no specific data are available on the prevalence of hypertension 
nation wide. Researches carried out in the mid 1950’s reported a prevalence of 
1.2 to 4%, but studies in the late 1980’s and 1990’s showed variation in the 
prevalence from 1 to 15%.  
The prevalence of hypertension in the metropolitan of Chennai and 
Mumbai has reached about 30 to 40%7,8.  
A pooling of epidemiological studies shows hypertension is present in 
25% of urban and 10% rural population in India9.            
It is estimated that the approximate number of persons affected by 
hypertension in India is 19,57,85,03610 in an estimated population of 
106,50,70,60711.  
 
 
 
 
 
  
 
 
 
 
 
Fig. 1 Prevalence of hypertension in India over the years 1998-2004* 
 
 
* Source: Gupta R: Trends in Hypertension epidemiology in India: J Hum 
Hypertens 2004: 18; 73-78. 
Chandigarh Urban 11.59%±1.0 [Chadha SL 1998]  
Rural 3.58%±0.5 [Chadha SL 1998]  
(13.11%±1.0  
(Thakur K 1999)  
Jaipur 
36.4%  Male  
37.5%  Female 
(Gupta R 2002) 
 
34.1%  
(Anand MP 2000) 
43.8% Male  
44.5% Female  
(Gupta PC 2004) 
31% Male,  
41.2% Female 
(Joseph A 2000) 
14%  
(Mohan V 2001)  
  
 
 
 
 
Definition12  
  Blood pressure in a population would be a typical bell shaped curve. An 
exact definition cannot be given as normotension and hypertension. The best 
operational definition is the level at which benefits of action exceeds the risks 
and costs of inaction due to hypertension.  
 As per JNC VII (2003) report hypertension is defined as systolic 
≥140mmHg and or diastolic ≥ 90mmHg. The JNC classification for blood 
pressure in persons aged >18 yrs is provided in Table 2:  
Table 2: JNC classification for blood pressure* 
BP classification SBP mmHg  DBP mmHg 
Normal  <120   and  <80 
Pre hypertension   120-139   (or) 80-89 
Hypertension  
Stage I 
 
140-159 
 
 
 
90-99 
Stage II ≥160  or ≥100 
 
* Source: 7th report of Joint National Committee on the prevention, detection, 
evaluation and treatment of high blood pressure (JNC VII). Chobanian AV, 
  
Bakris GL, Black HR, Cushman WC, Green LA. Hypertension 2003. Dec; 
42(6) 1206-52.  
 
 
 
Natural history of untreated hypertension  
 The pathological hallmark of hypertension is the accelerated 
atherosclerotic rigidity of large capacitance arteries which is evident by rising 
systolic and falling diastolic levels. The resultant widening of pulse pressure is 
said to be the best prognostic indicator for cardiovascular risk.  
 The MRFIT study had showed that each 20mmHg rise in systolic blood 
pressure and 10mmHg rise in diastolic pressure is associated with more than 
two fold increase in mortality from stroke and coronary artery disease13.  
 
Mechanisms of essential hypertension  
1. Hemodynamics  
     Blood pressure is the pressure required to move blood through the 
circulatory bed by pumping action of the heart and the tone of the arteries.  
Blood pressure (BP) = cardiac output × peripheral resistance  
Any factor which influences the above two factors could cause an 
increase in blood pressure.  
  
 
 
 
 
 
Fig 2: Factors determining blood pressure*  
 
* Source14: Vikrant S, Tiwari SC: Indian Academy of Clinical Medicine 
Journal 2001; 2(3): 14-157.   
Regardless of how hypertension begins, eventually increased peripheral 
resistance becomes the primary hemodynamic facet of sustained hypertension.  
2. Role of Genetics  
  
    Family aggregation of blood pressure has been demonstrated in family 
members and twins. Essential hypertension is almost certainly a polygenic 
disorder, involving multiple genes, each having a small effect on the blood 
pressure15.  Along with this multiple environment factors play a role 
interacting with the genes to skew the distribution of blood pressure to higher 
levels16.  
 The identification of various genes that contribute to the development of 
hypertension is complicated by the fact that the 2 phenotypes that determine 
blood pressure i.e., cardiac output and total peripheral resistance are in turn 
controlled by intermediary phenotypes including the autonomic nervous 
system, vasopresssor and vasodepressor hormones, the structure of the 
cardiovascular system, blood volume and renal function and many others17.  
Mutations in genes such as angiotensin gene, β2 adrenergic receptor, 
Adducin, renin binding proteins, G-protein β3 subunit, atrial natriuretic factor 
and insulin receptor has been linked to the development of essential 
hypertension, but most of them only show a weak correlation14.  
3. The Fetal Environment 
  Low birth weight has been found to be followed by an increased blood 
pressure18.  
  
 Despite objections of this theory Brenner and his colleagues 
hypothesized that IUGR affects nephrogenesis and this low number perhaps 
eventuates hypertension.  
4. Sodium and the Kidney  
 Essential hypertension is primarily due to an abnormal kidney which has 
an unwillingness to excrete sodium19. The contribution of sodium to blood 
pressure is probably due to sodium retention, the mechanisms by which it 
retains sodium are provided below and the same has been depicted in a pictorial 
manner in Fig. 3.  
- A decrease in the filtration surface by a congenital or acquired deficiency  
in nephron number or function20.  
- A resetting of the pressure natruiesis and pressure diuresis mechanisms21  
- An acquired inhibitor of sodium pump22  
- Nephron heterogeneity: The presence of subgroup of ischemic nephrons 
either from afferent arteriolar vasoconstriction or from an intrinsic 
narrowing of the lumen23. 
Figure 3: Sodium and blood pressure*  
  
 
* Source: Vikrant S, Tiwari SC: Indian Academy of Clinical Medicine Journal 
2001; 2(3):140-157.   
5. Vascular hypertrophy  
        A number of factors increase peripheral resistance by functional 
contraction, vascular remodelling and hypertrophy. These pressor growth 
promoters may result in both vascular contraction and hypertrophy 
simultaneously, but perpetration of hypertension involves vascular hypertrophy. 
Hormonal mediators such as angiotensin II and endothelin may serve as the 
initiator events to an increased peripheral resistance. Lever and Harrap 
postulated that essential hypertension is alike secondary hypertension in its 
history and has two stages 
1. Growth promoting process in children  
  
2. Self perpetuating mechanism in adults24.  
6. Renin - Angiotensin system  
         Renin acts as a direct pressor and a growth promoter and is likely to be 
involved in the pathogenesis of hypertension, when sodium intake is reduced or 
effective plasma volume shrinks. The increase in renin – angiotensin II 
stimulates aldosterone secretion which in turn is responsible for renal retention 
of sodium and water in essential hypertension. In contrary to the expectation the 
plasma renin activity is low only in 30% of patients whereas 50% have normal 
levels and the remaining 20% have high levels5. 
Three mechanisms have been suggested for the above phenomenon  
• Nephron heterogeneity  
• Non modulation  
• Increased sympathetic drive  
7. Sympathetic nervous hyperactivity  
 Young hypertensive patients tend to have increased levels of circulating 
catecholamines, augmented sympathetic nerve signals in muscles, faster heart 
rate, and heightened vascular activity to alpha adrenergic agonists25. 
 In the Framingham study in middle aged men over an 18 to 20 year 
period hypertension was more common in patients with heightened anxiety, 
suppressed expression and anger at baseline26. 
  
 These changes increase blood pressure by various mechanisms like an 
increase in renin release, increased cardiac output (or) by altering the nocturnal 
renal pressure – volume relationship.  
8. Hyperinsulinemia / Insulin resistance  
    Hypertension, hyperinsulinemia and obesity, especially obesity which is 
predominantly visceral and in the upper abdomen is a well known dangerous 
trio. The presence of hyperinsulinemia and insulin resistance27 is seen in about 
20% of non obese hypertensives.  
 The exact cause of insulin resistance in non-obese hypertensive persons 
is not known. It could simply reflect a reduced ability of insulin to reach the 
skeletal muscle cells, where the major peripheral action of glucose occurs. (This 
impairment may in turn result from a defect in the vasodilatory effect of 
insulin).  
 Insulin has multiple pressor effects including activation of sympathetic 
activity, trophic action on the vascular system causing hypertrophy and increase 
in renal sodium absorption. Normally the pressor effects are counteracted by 
insulin mediated increased synthesis of nitric oxide. In hypertension there is 
impairment in the insulin mediated increase in nitric oxide leading to a rise in 
the blood pressure.  
9. Endothelial dysfunction  
Nitric oxide  
  
A reduced vasodilatory response to various stimuli of nitric oxide release 
appears to be an independent factor for the origin of essential hypertension28.  
Endothelin    
 Endothelin -1 appears to be of particular importance because it causes 
pronounced and prolonged vasoconstriction and blockade of its receptors. Also, 
it improves endothelium dependent vasodilation in hypertensive patients, but its 
role in human hypertension is debatable29. 
10. Other possible mechanism / associations  
  Hypertension is associated with obesity, sleep apnoea, physical 
inactivity, alcohol intake, smoking, higher haematocrits, hyperlipidemia and 
hypercholesterolemia5.   
TARGET ORGAN DAMAGE 
 
 Target end organ damage can be defined as the organs affected by 
hypertension due to the increase in the blood pressure30. 
 
Hypertension and the heart  
 It can be classified into 
1. Left Ventricular hypertrophy 
2. Systolic and diastolic dysfunction  
 
  
Hypertension causes more than double the risk for symptomatic coronary 
disease, including acute myocardial infarction and sudden death and more than 
triples the risk for congestive heart failure31.  
The consequences reflect an admixture of effects induced by 
hypertrophic response of the left ventricle to the increased after load imposed 
by hypertension.    
Left ventricular Hypertrophy 
  This is the most important cardiac abnormality in hypertension. The 
normal left ventricle grows from infancy until adulthood32. Further increase 
may occur according to the haemodynamic load.   
 
 
a. Normal Left Ventricular size  
 Body surface area is generally taken into account for the left ventricular 
mass index, which was reported by Cornell and Framingham as 134gm/m2 and 
131gm/m2 in males while in females it was 109g/m2 and 100gm/m2 
respectively33,34.  
 The gender difference may reflect genetic, hormonal or exercise effects 
that influence both skeletal and heart muscle. Relation between age and left 
ventricular dimension or mass is either weakly positive or absent35. 
Prevalence  
  
    Left ventricular hypertrophy is identified by ECG in only 5 to 10% of 
hypertensives but left ventricular hypertrophy by echocardiography is seen in 
nearly 30% of unselected hypertensive patients36.  
 Fundoscopic changes (or) other target organ abnormalities used to 
classify patients as having stage 2 hypertension under WHO scheme have a 
high prevalence of echocardiographic left ventricular hypertrophy in one series 
of hypertensive patients.  
 The prevalence of left ventricular hypertrophy among hypertensive 
patients is influenced by gender and obesity. Sex specific criteria for left 
ventricular mass index identifies left ventricular hypertrophy more in women 
than in men as used in the Framingham population study.  
 
Pathogenesis / Factors influencing left ventricular hypertrophy 
     Although one might expect the elevated blood pressure would 
consistently induce left ventricular hypertrophy, the data reviewed doesn’t 
indicate the case37.  
a. Blood pressure  
 Left ventricular muscle mass is usually more closely related to systolic 
blood pressure than diastolic. Left ventricular mass in hypertensive patients is 
more closely correlated with systolic blood pressure at the end of maximal 
exercise than with the resting systolic pressure38.  
  
 A study in employed population revealed that blood pressure and left 
ventricular mass were high in jobs with high strain39.  
b. Haemodynamic volume overload  
  Supranormal cardiac output is a well documented phenomenon in high 
normal blood pressure and hypertension. Conversely low normal (or) 
subnormal cardiac output and stroke volume may occur with markedly elevated 
peripheral resistance in patients with relatively severe hypertension40.  
 The important role of volume load in pathogenesis of hypertension and 
left ventricular hypertrophy is underscored by the fact that left ventricular 
chamber size and stroke volume are more closely related than systolic pressure 
to left ventricular mass in normotensive and mildly hypertensive humans41. 
 
c. Blood viscosity  
 Left ventricular thickness and mass are directly related to the whole 
blood viscosity, extending the previous documentation of Strandell of the heart 
volume and haemoglobin42.  
NON HAEMODYNAMIC STIMULI TO HYPERTENSIVE LEFT 
VENTRICULAR HYPERTROPHY  
1. Sympathetic Nervous system  
    It is a controversial topic. The point favouring sympathetic nervous 
system and left ventricular hypertrophy is largely based on the concept that 
  
hypertrophy is due to excess catecholamines, in laboratory experiments43. But 
the points that suggest sympathetic nervous system has only a limited impact on 
left ventricular hypertrophy are:  
1. Haemodynamic pressure or volume load responses to adrenergic 
stimulation or blockade has not been characterised.  
2. Catecholamines do not induce hypertrophy of cultured adult cardiac 
myocytes.  
3. In patients with pheochromocytoma the state of hyperadrenergic 
hypertension have left ventricular hypertrophy that is proportional to 
their blood pressure and not to their catecholamine levels44.  
 
 
2. Renin – angiotensin system  
        This concept is of the changing trend. In the past an independent role of 
circulating or intracellular renin-angiotensin system in hypertensive left 
ventricular hypertrophy was to be proven and clinical studies found no 
difference in left ventricular mass among patients with high/normal (or) low 
renin forms of essential hypertension45.  
 But the present day trend is that there is a close correlation between the 
circulating levels of renin with left ventricular mass46 by the recognition of a 
close connection between left ventricular hypertrophy and a deletion 
  
polymorphism of the angiotensin converting enzyme gene the DD genotype, 
which increases plasma angiotensin converting enzyme activity47. The 
involvement of RAS and heart is further strengthened by the impressive effect 
of ACE inhibitors on the regression of left ventricular hypertrophy and 
remodelling of the heart after MI48.  
3. Increased Left Ventricular mass as a precursor of hypertension  
The possibility that left ventricular hypertrophy is not only a 
consequence but could also precede it49 was first raised by the observation that 
base line left ventricular mass in children and adults contribute independently to 
predicting their blood pressure 4 years later.  
The strongest predictor of subsequent hypertension was the initial left 
ventricular mass with additional independent prediction by the 24 hour urinary 
sodium/potassium excretion ratio5.    
Relation between cardiac and vascular changes in hypertension  
  Increased vascular resistance and vascular hypertrophy have been related 
to left ventricular adaptive changes but not in all studies. Geri et al found a 
weak but significant relation between calf vascular resistance and left 
ventricular mass50.  
    Schulte et al found a significant relation between forearm vascular 
resistance and left ventricular mass in hypertensive patients51.  
Patterns  
  
 The left ventricular hypertrophy may occur in any of the following 
forms. Concentric, eccentric remodelling (or) concentric remodelling or the 
mass may not be increased.  
Consequences of hypertensive hypertrophy  
      Increased left ventricular mass is a potent predictor of cardiovascular 
morbidity and mortality, independent of blood pressure or other risk factors.
 The Framingham heart study concluded that only left ventricular mass 
index and age were strong and consistent predictors of all the above.  
 
 
Systolic and diastolic dysfunctions5, 30  
 In contrast to general normality of systolic left ventricular performance 
in uncomplicated hypertension, left ventricular diastolic filling is abnormal in 
many adults.  
 Characteristically early diastolic left ventricular filling is impaired with 
normal (or) enhanced filling during atrial systole, identifying subnormal left 
ventricular relaxation but not compliance. Notably impaired left ventricular 
diastolic relaxation occurs in patients in whom extreme left ventricular 
hypertrophy with preserved systolic function is complicated by heart failure and 
reduced early diastolic left ventricular filling is strongly related to left 
ventricular mass. But diastolic left ventricular filling may also be abnormal in 
  
hypertensive patients with normal left ventricular anatomy and is usually 
normal in athletes with hypertrophy.  
 In established hypertension, abnormal relaxation has been observed in 
2/3rd of patients with normal left ventricular systolic function.   
 The spectrum of diastolic dysfunction courses on one end, from the 
failure of left ventricular end-diastolic volume to rise appropriately with 
exercise, all the way to the other end of left ventricular heart failure with 
normal systolic function with diastolic heart failure.  
 
 
Systolic dysfunction 
   In mild to moderately hypertensive patients left ventricular systolic 
performance at rest is normal (or) mildly increased. But it has been shown that 
left ventricular ejection fraction and fractional shortening measured at the 
endocardium to be normal (or) supranormal may reflect a “conceptual 
mismatch”. When the midwall shortening and end diastolic stress relations were 
analysed in relatively unselected hypertensive patients with concentric left 
ventricular hypertrophy, decreased myocardial contractility and no significant 
hypercontractility was observed in patients without left ventricular hypertrophy. 
In recent large studies a depression of left ventricular systolic function was 
found in 8.9-17.5% of patients.  
  
 
THE KIDNEY 
 
 
 The number of patients developing end stage renal disease secondary to 
hypertension is increasing and the mechanism involved in the sclerotic 
processes are not only a sequel of hypertension, but also contributes to its 
pathogenesis.  
 Looking back, Gull and Sutton were the first to suggest that a vascular 
disease has a primary pathologic role in hypertension. Jores in 1904 provided 
the anatomic basis for differentiating primary and secondary hypertension5.    
 
Various theories have been proposed about the kidney and hypertension5  
1. Renal disease is primary and that the associated vascular disease and 
hypertension were its results.  
2. Renal disease is a part of a primary vascular disease and the progressive 
vascular sclerosis increases peripheral resistance, resulting in systemic 
hypertension.  
3. Essential hypertension itself is a primary disease and the vascular diseases 
seen in all organs are a result rather than a cause.  
 
  
Whatever the theory may be but it is clear that vasculopathy of 
hypertension is a distinct and perhaps unique lesion which involves the kidney 
preferentially. 
Microvascular disease of the kidney5  
  The vessels most susceptible to hypertension are the small arteries, 
arterioles and the preglomerular vessels tend to be more prominently affected 
than that of the postglomerular arterioles.  
 The vascular pathology of the small arteries and arterioles of the kidney 
falls into 3 general categories.     
1. Hyaline arteriolar sclerosis  
2. Myointimal hypertrophy and hyperplasia  
3. Fibrinoid necrosis   
 The first form occurs in all forms of hypertension while the second and 
third are hallmarks of malignant hypertension.  
 We would see a few words about hyaline arteriolar sclerosis because the 
other two are hallmarks of malignant hypertension. 
Hyaline arteriosclerosis     
 The most interesting microvascular pathology is hyaline arteriosclerosis.  
This deposition of hyaline in small arterioles causes atrophy of the 
smooth muscle cells and irregular thickening of the basement membrane.  
  
Hyaline arteriosclerosis may be associated with aging but are usually 
minimal and focal and are not associated with elevations of diastolic blood 
pressure.  
The presence of hyaline is unrelated to age and it is related to both 
severity and duration of hypertension.  
The deposition of hyaline at the end, may result in a more or less fixed 
vascular lumen leading to an elevation of peripheral vascular resistance and 
relative – ischemia of the regions supplied by the vessel.  
Whatever may be the pathology it ultimately leads to albuminuria 
followed by nephrosclerosis.  
Albuminuria52          
 It is now accepted that microalbuminuria is a more generalized vascular 
problem and not just confined to the renal microcirculation.  
 An increase in urine albumin above the normal 30mg/dL is defined as 
albuminuria. Microalbuminuria is used to define smaller degrees of albuminuria 
(30-300mg/dL). False positive results may be observed in the presence of 
alkaline urine and following radio-contrast administration.  
Pathophysiology  
   The glomerular capillary wall provides a barrier to the filtration of large 
macromolecules. The barrier to filtration is provided by 2 mechanisms.  
1. Size selectivity  
  
2. Charge selectivity   
Size selectivity  
        The endothelial cells have fenestrations with an approximate radius of 
40nm and as such do not provide an effective barrier to albumin. The 
glomerular basement membrane and the foot processes of epithelial cells serve 
as the major components of size selectivity.  
Charge selectivity   
 The anions on the GBM provide the charge selectivity. Loss of the 
negative charge may result from the disruption of the epithelial cell barrier and 
may lead to albuminuria.  
 When there is damage to the basement membrane or components of the 
glomerular epithelial cells, often the first manifestation is the appearance of 
plasma proteins in the urine because albumin is the major circulating protein in 
plasma. Its appearance in the urine is the most sensitive indicator of disruption 
of the glomerular filtration barrier.  
 In both hypertensives and normotensives, the presence of 
microalbuminuria is correlated to the presence of left ventricular hypertrophy 
and the presence of microalbuminuria predicts increased risk of cardiovascular 
morbidity and mortality53. It has also been shown that there is a greater risk of 
hypertensive retinopathy and progressive atherosclerosis54.  
Incidence of microalbuminuria  
  
     The prevalence of microalbuminuria has been reported with variation 
between 5 and 37%.  
Factors determining albuminuria  
1. Genetic  
No specific gene could be positively correlated, but chromosome 10q 
has been implicated.  
2. Race 
Albuminuria is more common in African Americans / American Indians 
and Hispanics in western literature. There is no study in our population 
about the incidence of albuminuria.   
3. Sex  
It is twice more common in males than in females.   
 
4. Age  
Persistent albuminuria increases with age.   
5. Blood pressure  
There is increased albuminuria with increasing blood pressure.  
 
 Despite the strong epidemiological evidence of the association between 
hypertension and renal disease some authors question their relationship because 
randomized controlled trials have shown that the renal dysfunction developed 
infrequently during various treatment schedules of hypertension30.  
  
 However, it should be remembered that renovascular diseases are not an 
infrequent cause of renal insufficiency and hypertension.  
 
THE EYE 
 Patients with only hypertensive retinopathy are nearly always visually 
asymptomatic. In many instances the hypertension may be unknown to the 
patient and the eye examination may yield the first clue to this relatively 
asymptomatic disease55.  
 Elevation of systemic blood pressure causes both focal and generalized 
retinal arteriolar constriction, presumably mediated by autoregulation. A 
prolonged duration of particularly high blood pressure can be associated with a 
break down of the inner blood retinal barrier, with extravasation of plasma and 
red blood cells. Retinal haemorrhages, cotton wool spots (micro-infarcts), intra 
retinal lipid accumulation and in severe cases the development of a macular star 
may be seen55.  
 In severe hypertension, closure of retinal capillaries are observed. When 
the choroidal vessels are severely affected by elevated blood pressure, as in 
acute hypertension, fibrinoid necrosis of choroidal arterioles can cause 
occlusion, with subsequent break down of outer blood retinal barrier.  
 The relationship between pure hypertensive changes and arteriosclerosis 
are so complex that it is impossible to consider them  separately55.  
  
 A method of objectively evaluating retinal vessel calibres is from 
digitized fundus photographs.  
 The Beaver Dam study showed that narrowed retinal arterioles are 
associated with long term risk of hypertension suggesting structural alterations 
of the microvasculature may be linked to the development of hypertension. The 
Blue mountain eye study showed that the arteriolar narrowing of retinal vessels 
was a consequence of hypertension55.  
 The presence of hypertensive retinopathy diagnosed clinically was 
correlated with doubling of the risk of coronary heart disease events.             
 
 
 
Retinal changes and hypertension55  
a. Arteriolar narrowing  
   Diffuse arteriolar narrowing is a hallmark of hypertensive retinopathy. 
Although it can be seen as an acute vasospastic response to acute hypertension, 
it is more commonly seen in chronic hypertension. The reduction in the caliber 
of arterioles is largely responsible for the reduction of arteriole to venule ratio 
associated with hypertension.  
  
 Focal arteriolar narrowing is attributed to localized areas of spasm of 
arteriolar wall and can be reversible. Persistent focal arteriolar narrowing may 
be due to oedema in the wall of the arteriole or localized area of fibrosis.  
b. Arteriosclerosis  
 Hypertensive arteriosclerosis refers to the progressive increase in the 
elastic and muscular components of the wall of arteriole induced by long 
standing hypertension. With advancing age the same changes can occur and this 
is called as involutional arteriosclerosis.  
c. Sclerotic changes  
          Increased thickening of the arteriolar wall caused by the arteriosclerotic 
processes causes progressive change in the appearance of light reflex from 
arteriole. Normally the arteriolar wall is invisible, only a column of red blood 
cells in the lumen is visible, and this appears as the red line we recognize. As 
the wall becomes thickened, the light reflex loses its brightness and becomes 
broader, duller and more diffuse in nature. This is the earliest sign of 
arteriosclerosis.  
 With increasing thickening of the arteriolar wall and decreasing lumen 
the light reflex takes on the reddish-brown hue of the ‘copperwire’ reflex. As 
the process continues, there is further thickening of the arteriolar wall with 
associated reduction in the lumen. The arteriole assumes the appearance of a 
silver wire, when the column of blood can no longer be visualized.  
  
 Arteriosclerotic thickening of the vessel wall also affects the appearance 
of arteriolovenous crossing. The vascular sclerosis and glial proliferation 
contribute to the compression of the venule and constriction of its lumen, 
causing the appearance of arteriolovenous nicking.  
 The sclerotic changes can also cause deflection of venule as it crosses 
the arteriole.  
 Hypertensive choroidopathy and hypertensive optic nerve changes are 
seen in longstanding  hypertension.  
Classification of hypertensive and arteriosclerotic changes55  
          Two popular classifications are 
1. The Keith – Wagener – Barker classification (1939) – based on the level 
of severity of retinal findings.  
2. Scheie’s (1953) classification to quantify the changes of hypertension 
and arteriosclerosis separately in a five – stage classification.  
Central nervous system56 
  Hypertension is more strongly correlated with stroke than with heart 
diseases.  
Cereberovascular accidents  
 In hypertensives, nearly 80% strokes are ischemic, 5% are subarachnoid 
haemorrhage and 10 to 15% intra-parenchymal haemorrhage.  
  
 Isolated systolic hypertension in the elderly is associated with 2-4 times 
greater incidence of stroke than is seen in normotensive people of the same age.  
Cognitive impairment and dementia30 
 Hypertension is associated with impaired cognition in the absence of 
clinically evident cerebrovascular disease30. 
 Cognitive impairment is related to hypertension atleast upto the age of 
70 after which the relationship decreases.      
Other end organ damages30 
 Large vessel disease such as abdominal aortic aneurysm, aortic 
dissection, peripheral vascular disease and Takayasu’s disease are all related to 
hypertension and regarded as target organs of damage.  
 
 
 
 
 
 
MATERIALS AND METHODS 
 
I. Type of study    : Observational study  
II. Setting    : Department of Medicine  
Government Rajaji Hospital 
      Madurai.  
  
III. Collaborating Department  : Department of Cardiology  
      Madurai Medical College,  
      Madurai.  
IV. Duration of Study   : January 2005 – December 2005 
V. Ethical clearance   : Ethical clearance was obtained. A  
      Copy of the letter is enclosed in  
      Annexure I.   
VI. Consent     : Informed consent was obtained before  
      taking up each case for study  
VII. Inclusion criteria   : All newly diagnosed rural essential  
hypertensives of both sexes who were 
conscious, cooperative and free of 
overt comorbid illness were 
considered for the study.  
 
VIII. Exclusion criteria   : Patients who had any of the following  
      were excluded from the study.  
1. Age <25 or >75  
2. BMI <18 or > 25 
 
Cardiovascular system and respiratory system  
  
3. Patients with primary cardiac (or) pulmonary disease  
4. Patients with secondary hypertension  
 
Renal system  
5. Patients with macroalbuminuria / urinary infection 
6. Patients with renal failure  
7. Renal transplant patient  
Endocrine  
8. Patients with diabetes 
9. Patients with thyroid disorders or adrenal disorders  
Acute condition  
10. Acute myocardial infarction  
11. Acute cerebrovascular accident  
12. Acute medical emergencies or urgencies  
 
 
Others  
13. Patients with malignancy  
14. Bed ridden patients  
15. Psychiatric patients  
16. Uncooperative patients  
  
17. Pregnant women 
18. Women on oral contraceptive pills  
19. Living in Madurai city or any urban area  
Habits     
20. Patients who are alcoholics /smokers  
21. Patients who are on drugs / diuretics  
 
IX. Materials  
 A total of one hundred and forty seven (n=147) consecutive patients of 
newly diagnosed essential hypertension, attending the outpatient Department, of 
the Department of Medicine, Government Rajaji Hospital, Madurai were 
included for this present study based on a set of inclusion and exclusion criteria 
out of 450 persons seen. The exclusion of other patients is given in Figure 4 
below: 
 
 
Figure 4: Patient flow chart 
 
 
 
 
450 
patients 
Patients 
excluded from 
study   
Age > 75 - 5   33-cerebro 
vascular accident  
BMI <18 (or) >25 – 8   51-Renal problems 
On other drugs - 3  36-Cardiovascular 
causes  
Patients 
excluded from 
study   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
X. Methods  
 Selected socio-demographic, clinical and laboratory data were elicited 
from these patients and recorded in a proforma.  
1. Socio-demographic data  
• Age  
  
• Sex 
• Health seeking behaviour  
2. Clinical data  
• Clinical history was elicited in detail with special emphasis on 
headache, giddiness, palpitation, breathlessness, chest discomfort, 
swelling of legs, sexual dysfunction, sleeplessness etc.,  
• Systolic and diastolic blood pressure were measured using standard 
procedures. The procedure used to record systolic and diastolic blood 
pressures is detailed below.    
• Clinical examination with special attention for thyroid swelling, renal 
bruit, cardiac murmur and additional sounds.   
3. Laboratory data  
• Blood urea: Estimation done manually using diacetyl monoxime 
(DAM) technique.  
• Serum creatinine: Estimation was done using COBAS autoanalyser.   
• Blood Glucose: Estimation was done using COBAS autoanalyser.   
• Urine for microablumin: ELISA immunometric assay was used and 
read with NYCOCARD Reader II. The patients were explained the 
importance of bed rest and over night urine collection to avoid 
physiological and pathological variations.   
  
Single channel Electrocardiogram was done to measure the electrical 
activity of the heart. Echocardiogram was carried out at the Department of 
Cardiology for every case to assess the cardiac function and status. The 
parameters studied were  
1. Diastolic function indices  
a. Deceleration Time (DT) 
b. Iso Volumetric Relaxation Time (IVRT) 
c. Mitral E deceleration time  
d. Mitral E and A velocities   
2. Systolic function indices  
a. Ejection fraction (EF)  
3. Left Ventricular Mass  
Eye  
 An amydriatic ophthalmoscopic examination was done in all patients for 
hypertensive retinopathy.   
 
 
XI. Conflict of Interest   : Nil  
XII. Financial support    : This study did not receive any  
       financial support from any  
       organization.   
  
  
Data were entered in a predetermined proforma and later entered into a 
Microsoft excel spread sheet and analysed using SPSS Package.  
XIII. Limitations of the study 
1. As the inclusion criteria were rigid, the true number of cases will be 
more than the number of cases reported during the study period.  
2. Histopathological examination could not be done since the ethical 
committee did not approve for renal biopsy as it is an invasive 
procedure.    
3. As the hospital caters to low socioeconomic status people, BMI of these 
patients were <20. BMI was not correlated with the severity of target 
organ damage in the study population.  
4. Due to technical constraints, complete profile of lipids was not carried 
out.  
5. Elaborate investigations to exclude secondary hypertension could not be 
carried out due to technical constraints.  
 
XIV. DEFINITIONS USED FOR THE STUDY PURPOSE 
1. Essential hypertension  
 Hypertension was defined in accordance to the JNC-VII report1 as 
systolic blood pressure of 140mmHg and above, and (or) diastolic pressure of 
  
90 and above. The newly diagnosed patients were identified by the mean of 3 
relaxed, seated right arm readings. The diagnosis that the hypertension was 
essential and not secondary was made on the overall clinical impression only.  
2. Microalbuminuria  
  An overnight sample of urine was taken and a value of 20-200mg/L was 
defined as microalbuminuria.  
3. Hypertensive retinopathy55  
 Based on Keith-Wagener-Barker classification.  
I. There is minimal constriction of the retinal arterioles with some 
tortuosity. 
II. Retinal abnormalities include those of group I with more definite 
focal narrowing and arteriolovenous nicking in patients with minimal 
or other systemic involvement.  
III. Abnormalities of I and II along with hemorrhages and exudates and 
vasospastic changes, including focal arteriolar constriction and cotton 
wool spots.  
IV. The abnormalities listed above are present and are usually more 
severe and there is optic disc oedema, Elsching’s spots are present in 
some.       
Left ventricular hypertrophy  
Electrocardiography  
  
 Based on the electrocardiography satisfying either Sokolow-Lyon 
criteria or Cornell voltage criteria57, 58.  
Echocardiography  
   A left ventricular mass of 136 gm/m2 for males and 112 gm/m2 for 
females were taken as upper limit of normal values. Any value higher than the 
above values were taken as left ventricular hypertrophy.  
Diastolic dysfunction59  
 Normal mitral E/A: 1-2, values less than 1 were taken as diastolic 
dysfunction.  
 Deceleration Time: 160-240 m/sec. Values greater than 240 m/sec. 
indicated diastolic dysfunction.  
 Intraventricular Relaxation Time: 70-90 m/sec. Values greater than 90 
m/sec. indicated diastolic dysfunction.  
Systolic dysfunction60  
 An ejection fraction of 50-80% was considered within normal limits. 
Values less than that were considered as systolic dysfunction.  
RESULTS 
 
 A total number of 147 newly diagnosed essential hypertensive patients 
were studied. The 147 patients were categorized into 3 groups as per the age 
classification adopted by WHO. 
  
Table 3: Distribution of cases in Relation to Age & Gender 
Category Age  Group Male Female Total 
Young Below 45 11 (13.9%) 
13 
(19.1%) 
24 
(16.3%) 
Middle Age 45-65 47 (59.5%) 
47 
(69.1%) 
94 
(63.9%) 
Elderly 65 and above 21 (26.6%) 
8 
(11.8%) 
29 
(19.7%) 
Total - 79 (53.7%) 
68 
(46.8%) 
147 
(100%) 
 
In the table the percentage is divided in such a way that the total of all 
males and female are made upto 100%. The above is depicted in a pictorial 
manner below in fig 5.  
Fig 5: Distribution of cases in relation to 
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 The age range, median, mean, SD of the study population are provided in 
Table 4 below: 
 
Table 4: The Statistical Analysis of the Age and Gender  
 
  
 Male Female Total 
Mean 56.77 52.55* 54.82 
SD 10.16 9.15 9.90 
Range 28-74 29-74 28-74 
Median 56 52 54 
 
  * not significant  
 
 There was no significant statistical variation in the age of the patients 
taken into the study. Sub analysis with reference to age and gender also did not 
show any significant difference.  
 
 
 
 
 
 
Blood Pressure Analysis 
 Of the 147 patients studied, 23 patients had Isolated systolic 
hypertension of which 17 were male and 6 were female. The details of systolic 
  
blood pressure, diastolic blood pressure and mean arterial pressure of these 
patients are provided in Table 5 below, and in Figures 6 and 7 (on the left side). 
 
Table 5: The Analysis of Blood Pleasure in Respect to Gender 
 
Mean  ± SD Median Range 
 
Male Female Male Female Male Female 
Systolic BP 163.57±15.51 167.26±15.77 162 168 140-200 140-210 
Diastolic 
BP 
95.27± 11.37 104.08±15.75 94 100 72-130 72-148 
Total 
(All patients) Mean Median Range 
Systolic BP 165.27±15.68 164 140-210 
Diastolic 
BP 
99.34±14.72 98 72-148 
MAP 99.05±15.80 96.67 60-135 
 
MAP – Mean Arterial Pressure 
 
 
 
 
 
 
Distribution of mean ± SD of systolic blood pressure, diastolic blood 
pressure and mean atrial pressure in relation to age group and gender are given 
in Table 6 below: 
Table 6: The Age wise and Gender wise break up of mean  
  
Blood Pressure levels 
Age group (in years)  
Male Female 
B.P. <45 45-65 >65 <45 45-65 >65 
SBP 
152.36  
± 
13.76 
166.47 
± 
15.93 
162.75 
± 
13.06 
167.08 
± 
12.80 
165.87 
± 
16.41 
175.75 
± 
15.24 
DBP 
99.63 
± 
8.04 
97.36 
± 
11.00 
88.28 
± 
11.03 
104.00 
± 
17.60 
105.23 
± 
15.32 
97.50 
± 
15.55 
MAP 
85.94 
± 
14.96 
101.56 
± 
16.10 
104.09 
± 
15.14 
97.94 
± 
11.91 
95.71 
± 
14.95 
110.75 
± 
14.06 
 
All the patients belonged to low income group (as our hospital provides 
free service and used mostly by low socio economic group). Break up analysis 
in relation to gender revealed that diastolic blood pressure was significantly 
more in women patients. Interestingly, diastolic blood pressure was higher in 
women of all age groups and it was significant.  
 
Joint National Committee classification of patients  
 The 147 patients in the study group were classified into 2 groups as per 
JNC VII guide lines. Classification of cases under JNC class and gender as well 
  
as JNC class and age group are provided in Table 7 and 8 respectively.  The 
same is provided in a pictorial manner in figure 8 (on left side). 
Table 7: Classification of the Patients as per JNC VII  
Guidelines by Gender 
JNC Class Male Female Total 
I 22(27.8%) 15(22.1%) 37(25.2%) 
II 57(72.2%) 53(77.9%) 110(74.8%) 
 
Table 8: Categorization of Patients as per Age and  
Gender according to JNC  
JNC Category  
I II Total 
 
Age Group 
Male Female Male Female Male Female 
<45 
4 
(18.2%) 
4 
(26.7%) 
7 
(12.3%) 
9 
(17.0%) 
11 
(13.9%) 
13 
(19.1%) 
45-65 
12 
(54.5%) 
10 
(66.7%) 
35 
(61.4%) 
37 
(69.8%) 
47 
(59.5%) 
47 
(69.1%) 
>65 
6 
(27.3%) 
1 
(6.1%) 
15 
(26.3%) 
7 
(13.2%) 
21 
(26.6%) 
8 
(11.8%) 
 Statistical analysis of patients by gender and age with JNC classification 
was not significant. 
1. Microalbuminuria 
  
A value of less than 20mg/L denotes there is no microalbuminuria, but a 
value of 20-200mg/L indicates microalbuminuria. Patients with 
macroalbuminuria were considered under exclusion criteria.  
 Out of the 147 persons, 51 (34.6%) had microalbuminuria. Their gender 
and age group distribution are provided in Table 9 given below: 
 
Table 9: The Gender and Age wise Classification of Patients with 
Microalbumiuria 
Microalbuminuria 
Age Group 
Male Female 
Total 
<45 
4 
(16.4%) 
4 
(15.4%) 
8 
45-65 
13 
(52.0%) 
19 
(73.1%) 
32 
>65 
8 
(32.0%) 
3 
(11.5%) 
11 
 
Analyzing all the 147 patients, the amount of albumin excreted in the 
urine was found out, it had a mean of 35.54 mg ± 54.03 while the median was 
14 (range 2-200).  
Overall microalbuminuria was independent of age and sex.  
 Statistical analysis was performed to find out whether microalbuminuria 
had any relationship with the systolic blood pressure, diastolic blood 
  
pressure and mean arterial pressure using ‘t’ tests and there was no 
positive correlation. 
 
Microalbuminuria and retinopathy 
Statistical analysis was made to find out the relationship between retinal 
involvement and microalbuminuria, and it was identified that they were 
interdependent variables with statistical significance (p=0.001). The results of 
an ANOVA were 0.0002. The details of the relationship between 
microalbuminuria, retinal involvement and gender are given in Table 10.  
Table 10: Gender wise Classification of patients with Retinal Involvement 
with and without Microalbuminuria 
Retinal Involvement* 
Grade 0 Grade I Grade II & III Micro 
albuminuria M 
(%) 
F 
(%) 
Total 
(%) 
M 
(%) 
F 
(%) 
Total 
(%) 
M 
(%) 
F 
(%) 
Total 
(%) 
<20mg 
18 
(85.7) 
22 
(91.7) 
40 
(88.9) 
31 
(79.5) 
14 
(63.6) 
45 
(73.8) 
5  
(26.3) 
6  
(27.3) 
11 
(26.8) 
>20mg 
3  
(14.3) 
2  
(8.3) 
5  
(11.1) 
8  
(20.5) 
8  
(36.4) 
16 
(36.2) 
14 
(73.7) 
16 
(72.7) 
30 
(72.2) 
*p = 0.0001;    ANOVA = 0.0002 (Microalbuminuria vs Retinopathy vs gender) 
Microalbuminuria and left ventricular mass / diastolic function  
  
Diastolic dysfunction in patients was considered taking mitral E/A as the 
main parameter. 
Excretion of albumin in the urine is correlated with the level of left 
ventricular mass and the diastolic dysfunction of the left ventricle. The details 
are provided in Table 11and 12 respectively.  
Table 11: Relationship of Microalbuminuria with Left Ventricular Mass 
S.No 
Micro 
albuminuria  
No of 
Patients 
Mean 
LV mass 
S.D. t Value p value  
1 Normal 96 239.61 71.29 
2 Abnormal 51 268.00 78.51 
0.215 0.034  
 
Table 12: Mitral E/A’s relationship to microalbuminuria 
 Mitral E/A 
Micro 
albuminuria 
S.D. t Value p value 
Normal 96 1.646 0.522 
Abnormal  51 0.9527 0.469 
2.51 0.014  
 
 Left ventricular mass was greater in patients who had microalbuminuria 
than without and the difference was significant. Similar significance was noted 
with left ventricular diastolic dysfunction.   
  
 Using Chi square test and ‘t’ test it was found that Intraventricular 
relaxation time and Deceleration time were inter related. 
 
 Taking into account symptoms such as breathlessness, giddiness, chest 
discomfort and headache as comparable variables with microalbuminuria, a  
chi-square test was performed and none of the symptoms were positively 
correlated. 
 
2. RETINOPATHY  
 Out of the 147 persons in the study group, 102 (72.1%) of persons had 
retinal involvement. In the study Keith – Wagener – Barker classification was 
used. 45 persons had no retinopathy, 61 persons had Grade I retinopathy, 38 
persons had Grade II retinopathy, 3 persons had Grade III retinopathy and none 
had Grade IV retinopathy. The distribution of cases in relation to age and 
gender is shown in Table 13 (on the left side). 
 
Age group statistical analysis with retinopathy found no significance in 
the young and middle age groups. But significance between old age and 
retinopathy was found in the study group.  
 
 Analysis was done to see whether gender had any role in modifying 
retinal changes in hypertension and the analysis showed that gender had no role 
in altering the changes in the retina among the newly diagnosed hypertensives. 
  
 The distribution of patients with or without retinopathy in relation to age 
group is given in Table 14: 
 
Table 14:  Retinopathy in relationship to Age Group 
 
Age Group* (in years) Retinopathy 
Grade < 45 45-65 >65 
0 
12 
(50%) 
24 
(25.5%) 
9 
(31.0%) 
I 
6 
(25%) 
48 
(51.1%) 
7 
(24.1%) 
II & III 
6 
(25%) 
22 
(23.4%) 
13 
(44.9%) 
 
 * significant (p=0.01) 
 
 A chi square test to find out the significance was performed for the total 
study group against retinopathy and a p value of 0.01 was obtained which is 
significant. 
 
 
 
 
  
 Retinal changes were analysed against left ventricular mass and the 
details in relation to gender is furnished below in Table 15. Retinopathy was 
significantly (p=0.0001) correlated with left ventricular mass.  
 
 Table 15:  Retinopathy, Left ventricular mass and gender  
 
LV Mass 
Male  Female  
Total Retinopathy 
Grade 
Normal Abnormal Normal Abnormal Normal Abnormal 
Mean LV 
mass 
(gms) 
0 
13 
(46.4%) 
8 
(15.7%) 
13 
(68.4%) 
11 
(22.4%) 
26 19 201.05 
I 
12 
(42.9%) 
27 
(52.9%) 
3 
(15.8%) 
19 
(38.8%) 
15 46 275.59 
II & III 
3 
(10.7%) 
16 
(31.4%) 
3 
(15.9%) 
19 
(38.8%) 
6 35 267.68 
Total 
28 
(100%) 
51 
(100%) 
19 
(100%) 
49 
(100%) 
47 100 248.10 
 
 
 
 
 
  
There is a significant variation in left ventricular mass with retinopathy 
in grade II and III retinopathy but it is not significant when compared with 
grade I retinopathy. Their details in relation to gender are provided in Table 16 
given below:   
Table 16: Gender, Retinopathy and Left ventricular mass in gms 
Male Female 
Retinopathy 
Grade 
No. of 
patients  
Mean LV 
mass  
(gms)  
No. of 
patients  
Mean LV 
mass  
(gms) 
t value p value 
0 21 220.198 24 181.92 2.17 0.037 
I 39 274.23 39 274.23 0.14 0.89 
II & III 19 294.95 22 240.41 2.64 .013 
 
a) Statistical analysis using ANOVA found the diastolic dysfunction (mitral 
E/A) was significantly correlated (p=0.00005) with changes in the retinal 
due to hypertension. 
b) A chi square test performed with IVRT / Deceleration time against 
retinal changes found that they were positively correlated with 
significance values of 0.0001 and 0.00025 respectively. 
  
c) Retinal changes were also analysed against giddiness, headache, 
breathlessness, chest discomfort, education and income status and was 
found to have no positive correlation.  
Left Ventricular Mass 
The analysis of left ventricular mass among the study population ranged 
from 83 to 409 gms.  The mean and median were 249.46 ±74.85 gms and 260 
gms respectively. 
The left ventricular mass was calculated among male and female 
population. It was 264.85±71.79gm and 231.59±74.86gm respectively. The 
statistical analysis revealed that left ventricular mass was more in men and it 
was significant as shown in Table 17. 
Table 17: Left Ventricular Mass and Gender 
Gender 
No. of 
Cases 
Mean t value p Value 
Male 79 264.85±71.79 
Female 68 231.59±74.86 
2.74 0.007 
 
 There is a significant difference in the left ventricular mass between the 
male and female gender. However when age was correlated with left ventricular 
mass it was found to be independent of left ventricular mass. 
 
  
Out of the 147 persons in the study, 100 individuals (68.0%) had left 
ventricular hypertrophy, which comprised of 51 males (64.6%) and 49 females 
(72.1%).   
 Left ventricular mass was not related to stage I of JNC (p=0.63) whereas 
a significant correlation with stage II JNC (p=0.01) was noticed. This indicates 
that when men progress to JNC class II their left ventricular mass increases. 
The details are provided in Table 18. 
Table 18: Left Ventricular mass, JNC and Gender 
Gender 
Male Female 
S. No. JNC 
No. of 
cases 
Mean LV 
mass 
(gms) 
No. of 
cases 
Mean 
LV mass 
(gms) 
t value 
p 
value 
1 I  22 226.05 15 237.47 0.49 0.63 
2 II 57 279.82 53 229.92 3.58 0.01 
 
The number of cases of Left ventricular hypertrophy diagnosed by 
echocardiography was greater than that diagnosed by electrocardiogram. The 
difference was statistically significant (p=0.0003). The details are shown in 
Table 19.  
 
 
  
Table 19: Electrocardiogram and Echocardiogram in relation to  
Left Ventricular hypertrophy 
Electrocardiogram  
(RV6+SV1) 
Echo 
cardiography  
<35mm >35mm 
Significance 
Normal  46 1 
Abnormal  73 27 
0.0003 
 
 Analyzing left ventricular mass with deceleration time, intraventricular 
relaxation time and mitral E/A it was found that all the variables were 
interdependent with a significant correlation between them. 
 
Symptoms and left ventricular hypertrophy  
There was a significant correlation (p = .0.15) between left ventricular 
mass and giddiness (Table 20) but no association could be found with other 
symptoms such as headache, breathlessness and chest discomfort.  
Table 20: LV Mass grouped and Giddiness 
Left ventricular Mass  
Giddiness Normal Abnormal 
 
Significance 
No 30 82 
Yes 17 18 
0.015 
  
 
 
  
Diastolic dysfunction 
Diastolic dysfunction can be calculated using mitral E/A, deceleration 
time or intraventricular relaxation time. In this study it was analysed using 
mitral E/A. The patients in the study who had diastolic dysfunction had it of 
grade I only. The mean mitral E/A, and the median were 1.091±0.513 and 0.91 
respectively. 86 persons (58.5%) had diastolic dysfunction, of which 53 
(67.1%) were males and 33 (48.5%) were females.  
Mitral E/A, Age group and Gender  
When mitral E/A was analysed to find whether any correlation existed 
between age and gender, no association could be found out. The details are 
produced in Table 21.  
Table 21: Gender, age group and mitral E/A 
Age Group (in years) 
<45 <45-65 >65 
Male  Female Male Female Male Female 
Mitral 
E/A 
No of 
patients 
4 
(15.4%) 
11 
(31.4%) 
17 
(65.4%) 
22 
(62.9%) 
5 
(19.2%) 
2 
(5.7%) 
>1 
61 
(41.5%) 
7 
(13.2%) 
2 
(6.1%) 
30 
(56.6%) 
25 
(75.8%) 
16 
(30.2%) 
6 
(18.2%) 
<1 
86 
(58.5%) 
  
 
 
 
  
Distribution of cases to IVRT and DT is shown in Table 22. The 
variables were significantly associated.  
Table 22: Intraventricular Relaxation time (IVRT) and  
Deceleration Time (DT) 
 Normal  Abnormal  
IVRT 
66  
(44.9%) 
81  
(55.0%) 
DT 
75  
(51.6%) 
72 
(49.0%) 
 
A correlation matrix was made with retinopathy, microalbuminuria, left 
ventricular dysfunction (Mitral E/A) and left ventricular mass along with 
systolic blood pressure and diastolic blood pressure. The matrix is analysed in 
such a manner to find out which variable influences the other. The details are 
provided in Table 23 provided below:  
Table 23: Correlation between major variables of the study 
Correlation BP diastole Retina 
Micro 
albuminuria 
Mitral 
E/A 
LV 
mass 
MAP 
BP Systole 0.2892** 0.2284* 0.1143 0.0393 0.0222 0.8186** 
BP Diastole  0.1810 0.1215 0.0304 0.0661 0.3130** 
Retina   0.3309** 0.2882** 0.3461** 0.1176 
Micro 
albuminuria    0.2898
**
 0.2734** 0.0405 
Mitral E/A     0.5807** 0.0208 
LV mass      0.0176 
2 tailed significance 0 .01*    0.001. ** 
  
Microalbuminuria: 
It was not dependent on blood pressure levels, but it is positively 
correlated with retinal changes, diastolic dysfunction and left ventricular 
hypertrophy. 
 
Retinal changes 
 There was positive correlation between retinal changes and systolic 
blood pressure but was not with diastolic blood pressure (or) mean arterial 
pressure. 
 The retinal changes, microalbuminuria, left ventricular mass and 
diastolic dysfunction are all interdependent variables. 
 
Left Ventricular Mass 
 Overall there was no relation between Blood pressure and left ventricular 
mass, but a relationship of left ventricular mass with microalbuminuria and 
diastolic dysfunction was identified. 
 
Diastolic Dysfunction 
 A relationship of mitral E/A with left ventricular mass and 
microalbuminuria was noticed, and no other factors influenced this variable. 
 None of the patients in the study group had systolic dysfunction.  
 
  
Regression Equations  
 Regression equations were prepared to find out the left ventricular mass 
from microalbuminuria as well as electrocardiogram. The regression equations 
were formed taking the results obtained from the study. 
 
1. To find out left ventricular mass with microalbuminuria levels  
Left Ventricular mass = 236.007 + (0.3786 x microalbumin level) 
2. To find the left ventricular  mass from Electro cardiogram  
Left Ventricular Mass = 181.278 + [2.860 x (RV6+SV1)]  
 
Considering the whole study group of 147, the number of patients having 
one target organ damage or the other was observed in 126 (85.7%) of which 
males contributed to 70 while females were 56 in number, with a statistical 
significance among them (p=0.054). 21 (14.03%) cases did not have any target 
organ damage at all, while in 33 patients (22.4%) all the target organs screened 
were affected.    
 
 The target organ damage in relation to males and females are depicted in 
Figure 10 and 11 respectively (on the left side).  
 
 
 
  
DISCUSSION 
 
Hypertension is undoubtedly the most prevalent form of cardiovascular 
disease. It is present in nearly 25% of the adult population and the prevalence 
increases with age.  
 As the population becomes older and more obese, the incidence of 
hypertension continues to increase, and with the added disadvantage of the 
asymptomatic nature of the disease, it slowly but steadily damages the target 
organ (or) end organs i.e. the heart, kidneys, eye and the brain30.  This is why 
Janeway and Walhard in the late 19th century aptly described Hypertension – 
“The silent killer”61.  
  In this study only patients with normal BMI were taken, as obesity may 
be a contributory factor for hypertension. Smokers and alcoholics were also not 
included in the study since it may influence the rate at which target organ 
damage would occur as suggested by the LIFE study62 in which smokers had an 
increased microalbumin excretion. 
Out of the 147 patients, there were 79 males and 68 females; the mean 
age was 54.9±10.12 years. This is in contrast to other studies such as the 
MAGIC study63 which had mean age of 51±0.06 years. Ceresola64 et al reported 
a mean age of 44±0.5 years and Leoinci et al65 reported 47±9 years. The 
difference in the mean age could be because of the late presentation of our 
  
patients to the doctor. Late arrival may be related to the socio cultural reasons 
or belief in alternative systems of medicine.  
 The mean systolic blood pressure in the study was 165.27±15.68 and 
mean diastolic blood pressure was 99.34±14.72, but to the surprise the mean 
systolic blood pressure and diastolic blood pressure was more in females. It was 
about 5mmHg in systole but was not significant statistically, whereas a 
statistically significant variation of diastolic blood pressure (9mmHg) was 
noted in women.  
 
Microalbuminuria  
In the present study of 147 patients, 51 patients (34%) had 
microalbuminuria of which males contributed to 25 (of 79) and females 
contributed to 26 (of 68). There was no gender predominance and it was also 
independent of age in contrast to some of the published reports65,67.  
The MAGIC study reported a prevalence of microalbuminuria as 6.7%63, 
while Agewall et al reported a 23% prevalence in patients undergoing treatment 
for hypertension66. Studies from Italy done by Leoncini65 showed it to be as 
13%, while a study in Madrid (Spain) by Martinez and his colleagues67 revealed 
7.2%. The LIFE study62 and studies by Ponteremoli68, showed prevalence rates 
of 23% and 14% respectively.  
  
The prevalence of microalbuminuria found in western literature varied 
from as low as 4.7% to as high as of 40%69. Comparing with Indian statistics 
Ghai70 reported a prevalence of 21.54%, but Jacob Abraham71 had reported as 
prevalence of 58%.  
A significant variability in the prevalence of microalbuminuria was 
attributed to the various values used to define it and the different techniques and 
protocols used to evaluate it. The prevalence of microalbuminuria was lower 
when only one overnight sample was taken for quantifying the result. A 24 hour 
urine collection would have given a higher value than an overnight sample 
because of the influence of food and physical activity on urinary albumin 
excretion. Due to the relative stability of renal haemodynamics at night, the 
results are reproducible with an overnight sample. So overnight sample 
collection was adopted in this study.  
Since smokers and alcoholics were excluded from study population, it is 
likely that hypertension was the single most predominant risk factor to cause 
microalbuminuria in both genders.  
 In this study the blood pressure levels did not correlate with 
microalbuminuria levels in contrast to Martinez Maria67 study group, hence it is 
likely that the duration of hypertension might have been contributed for 
glomerular changes, thus resulting in microalbuminuria. 
  
 Among the study group, a close relationship between retinal changes and 
microalbuminuria was noticed. Increasing grade of retinopathy as per Keith-
Wagener and Barker classification, the probability of the patient developing 
microalbuminuria was greater. This was similar to that observed by Cuspidi et 
al73. Bisenbach et al74 described a higher prevalence of coronary artery disease 
and hypertensive retinopathy in patients with persistent microalbuminuria.  
 The MAGIC study63 also suggested that patients with microalbuminuria 
were characterised by diffuse vascular and target organ damage i.e. retinal 
changes.  
 This study revealed that the presence of retinopathy was more or less 
mandatory for the appearance of microalbuminuria. 
 Going by previous studies by Redon et al75 who found out that patients 
with microalbuminuria showed a higher degree of left ventricular hypertrophy 
which was further confirmed by Cerasola et al64. Cuspidi et al73 also found a 
positive correlation with microalbuminuria and left ventricular hypertrophy. 
From India Jacob Abraham71 reported that proteinuria was significantly 
commoner in patients with left ventricular hypertrophy than in the control 
group. 
 Microalbuminuria when analysed in relation to left ventricular mass and 
mitral E/A independently, microalbuminuria was found to be directly 
proportional to left ventricular mass, but inversely proportional to mitral E/A.  
  
 A regression equation was also calculated from the study group having 
microalbuminuria and left ventricular mass. Using microalbuminuria levels left 
ventricular mass can be calculated using the formula in hypertensive patients.  
 
Left Ventricular mass = 236.007 + [(0.3786) × microalbuminuria] 
 
 Diastolic dysfunction in the form of mitral E/A, IVRT (or) deceleration 
time had a significant correlation with the microalbuminuria.  
 
RETINOPATHY  
Prevalence  
 The prevalence of hypertensive retinopathy in this study was 72.1% and 
a comparative analysis of retinopathy in different series are provided in Table 
24 given below:   
Table 24: Retinopathy among Hypertensives 
Study Prevalence 
Cerasola G et al64 54.83% 
Jacob Abraham et al71 65.00% 
Cuspidi C et al73 80.00% 
Cuspidi et al75 80.00% 
Present study  72.10% 
 
  
In the present study there were no variations in the pattern of retinopathy 
in relationship with gender. A significant correlation of retinopathy was 
observed with old age, and no correlation was noted in the middle and younger 
age groups. The significance in elderly could be due to the arteriosclerotic 
changes combined with hypertension.  
 Retinopathy had a positive correlation (p=0.001) with left ventricular 
mass in this study, but Jacob Abraham et al71 did not find any correlation 
between retinal changes and left ventricular hypertrophy.  
The mean left ventricular mass was more in the Grade I hypertensive 
retinopathy group, than the group which had Grade II and III hypertensive 
retinopathy thus indirectly stating that additional factors like genetic factors 
might have influenced the appearance of retinal changes which needs further 
evaluation and confirmation. 
 Going on to analysis of left ventricular mass and retinopathy with 
gender, there was significant influence of the male gender with grade II and 
grade III hypertensive retinal changes put together, but it was not so in those 
with grade I hypertensive retinopathy.  Retinal changes also correlated very 
well with diastolic dysfunction i.e. mitral E/A, intraventricular relaxation time 
and deceleration time.  Retinal changes when analysed with the symptoms, no 
positive correlation could be obtained.  
  
 Cuspidi76 and his co-workers suggested in their study that stage I and II 
hypertensive retinopathy were not associated with cardiac or extracardiac target 
organ damage, but in the present study even grade I and II retinopathy had been 
associated with significant target organ damage. Thereby indicating that 
duration of hypertension could have contributed for Target organ damage.  
LEFT VENTRICULAR MASS  
 In this study the mean left ventricular mass among the 147 patients 
studied was 249.46±74.85gms. Among the males and females, left ventricular 
mass of 264.85±71.79, and 231.59±74.86 gms respectively, and further 
comparative analysis revealed a statistical difference (p=.007) among them. Out 
of the 147 patients, 100 patients (68%) had left ventricular hypertrophy.  
Cuspidi et al73 reported from Italy a prevalence of 22%, while 
Pontermoli reported from Italy a prevalence 47%65, Jacob Abraham71 from 
Bangalore, India reported a prevalence of 53% in hypertensive population. The 
higher prevalence noticed in this study would be due to the late presentation of 
these patients to the health sector.  
 When left ventricular hypertrophy was analysed with JNC classification 
there was no correlation of left ventricular mass with stage I, but there was a 
statistical relationship with stage II of JNC. This indicates that those with 
higher blood pressure are likely to have greater left ventricular mass.  
  
 As seen from literature increase in left ventricular mass causes diastolic 
dysfunction. A positive correlation between left ventricular mass with mitral 
E/A value, deceleration time and intraventricular relaxation time was noticed 
among the study population.  
 The study also concurred with a well known fact that echocardiogram is 
a better investigation than electrocardiogram to diagnose left ventricular 
hypertrophy.                
Diastolic dysfunction  
 Diastolic dysfunction in this study was calculated using mitral E/A. 
There was no significant correlation of diastolic dysfunction with age and 
gender. Previous observation and a report by Marianne Hartford et al77 revealed 
that greater the left ventricular mass the more the diastolic dysfunction. This 
study also goes in the same line.  
Symptomatology  
Zampaglione et al78 reported some symptoms correlated with end organ 
damages. None of the symptoms could be positively correlated with target 
organ damage, other than giddiness which had an association with left 
ventricular mass (p = 0.015) in this study group.  
 
 
  
Target Organ Damage  
In this study, 126 persons (85.7%) of the 147 persons studied, had atleast 
one target organ damaged, it is much higher than that reported by Viazzi et al79 
from Italy who reported an incidence of 61%, this difference could be due to 
the late presentation our patient to the doctor. 
 Since one or other Target organ damage was observed in nearly all 
newly detected rural essential hypertensives, there is a urgent need to design 
and implement National Hypertension Detection and Control Programme by the 
Ministry of Health and Family Welfare, Govt. of India with the help of 
professional medical associations and non governmental organizations. It is 
time to act, better late than never, in order to prevent or minimize hypertension 
induced complications.       
 
 
 
 
 
 
  
CONCLUSIONS 
 
1. The prevalence of one (or) other Target organ damage was observed in 
126 persons (85.7%) of the newly detected rural essential hypertensives.  
2. The prevalence of retinopathy, left ventricular hypertrophy, diastolic 
dysfunction and microalbuminuria was observed in 72.1%, 68%, 58.5% 
and 34.6% respectively.  
3. Microalbuminuria was significantly associated with retinopathy, higher 
left ventricular mass and diastolic dysfunction but not to age and gender.  
4. Presence of microalbuminuria indicated widespread vascular damage.  
5. Microalbuminuria was independent of blood pressure levels. 
6. The study showed a correlation of retinopathy and systolic blood 
pressure, but not with diastolic blood pressure or mean arterial pressure.  
7. Retinopathy had correlated positively with left ventricular mass and 
diastolic dysfunction irrespective of age and gender.  
8. Left ventricular mass and diastolic dysfunction was inter-related.  
9. When all Target organ damage were put together and were considered 
for gender difference, Target organ damage was significantly more 
among males (p=.054).   
 
  
SUMMARY 
 
 Hypertension and target organ damage is a well known phenomenon. 
The study was undertaken to find the pattern of target organ damage in newly 
diagnosed non alcoholic, non smoking, non overweight, non dyslipidemic 
essential hypertensives of rural, low socio-economic status patients attending 
Government Rajaji Hospital, Madurai.  
 Thus 147 patients were taken up in the study group based on the rigid 
inclusion and exclusion criteria after institutional ethical clearance and an 
informed consent, out of 450 patients over a period of 12 consecutive months. 
Their sociodemographic, clinical and laboratory data were collected and 
analysed statistically.   
There were 79 (53.7%) males (age range of 28 to 74, mean ± SD 
56.7±10.16 years) and 68 (46.8%) females (age range of 29 to 74, mean ± SD 
52.5±9.15 years) without statistical difference in their age distribution.  
 Their systolic blood pressure, diastolic blood pressure and mean arterial 
pressure ranged from 140 to 210, 72 to 148 and 60 to 135 respectively, and the 
mean (±standard deviation) was 165.3 (±15.7), 99.3 (±14.7) and 99 (±15.8) mm 
of Hg respectively. 
Mean systolic blood pressure was more among females (167.26±15.77 
mmHg) than males (163.57±15.51mmHg), similarly diastolic blood pressure 
  
was also more among them (104.08±15.75) than their counterparts 
(95.27±11.37) thus identifying them to be a vulnerable population hitherto 
undetected. Hypertension was classified according to JNC VII, as stage I in 37 
patients (25.2%) and stage II in 110 patients (74.8%). Isolated systolic 
hypertension was observed in 17 males and 6 females. 
Microalbuminuria was seen in 51 cases (34.6%), and it was independent 
of age, sex, blood pressure status but it significantly correlated with retinal 
involvement (p=0.001), left ventricular mass (p=.034) and diastolic dysfunction 
(p=.014).  
 Overall retinal involvement was seen in 102 (72.1%). Retinal changes 
were significantly more in those with increased left ventricular mass and 
diastolic dysfunction. 
 The mean left ventricular mass was higher among males (264.85±71.79 
gms) than females (231.59±74.86) and it was statistically significant. Left 
ventricular mass though increased with blood pressure, it was not significant 
statistically. At the same time left ventricular mass correlated with diastolic 
dysfunction, thus indicating that end organ damage has multiple factors viz., 
genetic susceptibility, endothelial damage, duration of blood pressure, 
subclinical stress.    
 Moreover the clinical symptom of giddiness was significantly more 
(p=0.015) among those patients with a higher left ventricular mass. 
  
 In view of the covert end organ damages viz., microalbuminuria, 
retinopathy, higher left ventricular mass and left ventricular dysfunction that 
were observed among newly detected non overweight, non smoking, non 
alcoholic, non dyslipidemic newly detected essential hypertensives of rural 
areas, there is an urgent need to design and implement “National Hypertension 
Detection and Control Programme” by the Ministry of Health and Family 
Welfare, Govt. of India with the help of professional medical associations and 
non governmental organizations. It is time to act, better late than never, in order 
to prevent or minimize hypertension induced complications.     
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ANNEXURE I 
Approval letter from the Ethical Committee 
 
  
 
  
ANNEXURE II 
PROFORMA 
 
TOD AMONG NEWLY DETECTED RURAL HYPERTENSIVES 
Name:    OP No.:    Age:    Sex:   
Sl. No.   General examination   Investigations   
Complaints    Anaemia   Blood sugar   
Giddiness    Jaundice   Urea   
Palpitation    Cyanosis   Sr. Creatinine   
Dyspnoea    Clubbing   Sr. Cholesterol   
Chest discomfort    LNE    
Headache    Pedal oedema  ECG  
Vertigo    Pulse rate   /min   HR   
Weakness   BP Rt UL – mmHg  PR  
Swelling of legs    CVS  QRS      QT  
Others    Apical Impulse     
Personal History    JVP  AXIS  
Smoker    Pericardium Pulsations   ST – T Segment   
Alcoholic    Epigastric pulsations   Q Waves  
Family History    S1    
DM   S2    
HT   Added sounds   Income   
CAD   Murmur  Education   
Past History   RS  Weight   
DM   Breath Sounds   Height   
TIA   Added Sounds   BMI  
CVA   CNS    
  
ECHO CARDIOGRAPHY 
 
a. Diastolic function indices  
 1. Mitral E  Mitral A  Mitral E/A 
 2. IVRT 
 3. Deceleration Time (DT) 
b. Systolic function indices  
  Ejection Fraction  % 
c. Left Ventricular Mass  
d. Valves  
 
Retinopathy  
Microalbuminuria  
SL NO SEX AGE BP(SYS) BP(DIA) JNC RETINA ALBUMIN IVRT DT MITRAL E/A LV MASS RV6+SV1
1 1 60 174 72 2 1 5.0 2 2 0.67 332 15
2 1 45 156 90 1 0 19.0 1 1 1.14 115 23
3 2 30 170 140 2 0 72.0 1 1 1.09 205 12
4 1 64 200 100 2 1 23 1 1 0.83 242 37
5 1 40 150 90 1 3 30 2 2 0.67 361 42
6 1 46 140 118 2 1 5.0 1 1 0.58 306 38
7 2 37 150 86 1 0 5.0 1 1 1.2 234 36
8 1 56 150 104 2 1 20.0 1 1 1.3 179 15
9 1 56 170 80 2 1 7.0 1 1 2.2 200 30
10 1 70 190 90 2 0 20.0 1 1 0.67 170 22
11 2 42 188 110 2 0 5.0 1 1 1.3 147 24
12 2 50 190 110 2 1 18.0 1 1 1.2 209 30
13 1 40 140 92 1 0 6.0 2 2 1.5 187 23
14 2 50 140 120 2 1 200 2 2 0.27 383 23
15 1 40 160 110 2 1 18 2 1 2.8 298 37
16 1 65 150 90 1 2 94 1 1 1.7 154 15
17 2 67 180 120 2 2 42 1 1 2 83 13
18 1 60 200 130 2 2 50 2 2 0.66 143 13
19 1 70 170 110 2 2 2 2 2 0.75 400 38
20 1 60 160 92 2 1 2 2 2 0.8 340 8
21 2 53 170 108 2 0 5.0 1 1 1.4 111 27
22 2 56 176 106 2 0 27 1 1 1.3 162 14
23 1 74 142 92 1 0 20 2 2 0.8 290 25
24 1 52 164 108 2 1 8 2 2 0.8 274 26
25 2 50 182 132 2 0 7.0 1 1 1.4 214 18
26 2 50 176 96 2 0 5.0 1 1 1.05 152 19
27 2 70 188 102 2 2 13.0 2 2 0.8 249 23
28 1 70 170 72 2 1 5.0 2 2 0.88 274 38
29 2 57 140 90 1 0 5.0 1 1 1.25 150 12
30 2 47 142 86 1 2 72.0 2 2 0.88 263 16
31 2 65 168 90 2 2 9.0 2 2 0.625 267 36
32 2 45 180 100 2 0 12 1 1 1.12 123 24
ANNEXURE - III
MASTER CHART
SL NO SEX AGE BP(SYS) BP(DIA) JNC RETINA ALBUMIN IVRT DT MITRAL E/A LV MASS RV6+SV1
33 1 48 150 90 1 1 72.00 2 1 1.3 214 19
34 2 55 210 112 2 1 18.5 2 2 0.7 285 26
35 1 67 162 88 2 0 7.0 2 2 0.8 313 22
36 1 74 162 72 2 0 5.0 1 1 2.4 192 30
37 1 49 158 102 2 1 12 2 2 0.54 409 25
38 2 49 156 110 2 2 21.0 2 1 1.16 203 13
39 2 50 188 146 2 1 100 2 2 0.75 309 14
40 2 48 168 102 2 2 112 1 1 0.8 180 14
41 1 65 180 80 2 0 72.00 2 2 0.71 190 18
42 2 61 172 100 2 2 39 1 1 0.75 206 18
43 2 55 150 100 1 2 74 1 1 0.6 229 20
44 2 41 168 94 2 0 9.0 1 1 1.65 120 28
45 2 50 160 100 2 1 19 1 1 1.4 147 20
46 2 50 162 108 2 0 5.0 1 1 1.6 195 20
47 1 40 140 100 2 1 12 2 2 0.9 308 25
48 2 60 180 90 2 1 72.00 2 2 0.2 265 25
49 2 47 152 98 1 0 5.0 2 2 0.2 264 15
50 1 70 148 88 1 1 5.0 2 2 2.72 272 19
51 2 65 150 90 1 2 5.0 2 2 0.27 279 38
52 2 55 162 88 2 1 134 2 2 0.6 401 16
53 2 57 180 130 2 1 7 2 2 0.23 340 15
54 2 60 148 92 1 0 9 1 1 2.5 230 17
55 2 29 176 132 2 2 24 2 2 2.81 251 32
56 2 45 176 98 2 2 36 2 2 0.87 350 24
57 2 62 158 102 2 1 15 2 1 0.75 287 11
58 2 35 174 126 2 2 32 2 1 1.5 278 38
59 2 45 150 92 1 1 5 1 1 0.73 374 16
60 1 67 160 90 2 1 18 2 2 0.94 290 39
61 1 56 168 104 2 0 8 2 2 0.64 282 17
62 1 60 192 98 2 3 29 2 2 0.81 349 20
63 1 58 156 96 1 1 5.0 2 2 0.6 287 20
64 1 54 184 90 2 1 29 2 2 0.73 285 28
65 1 28 152 102 2 2 72.00 2 2 0.6 319 36
66 1 51 178 90 2 2 5.0 2 2 0.6 326 25
67 1 54 178 94 2 2 20 2 2 0.75 274 38
SL NO SEX AGE BP(SYS) BP(DIA) JNC RETINA ALBUMIN IVRT DT MITRAL E/A LV MASS RV6+SV1
68 1 44 182 98 2 1 32 2 2 0.75 405 40
69 2 48 158 92 1 0 18 1 1 1.33 250 30
70 2 37 148 92 1 0 16 1 1 1.64 102 18
71 1 54 148 98 1 0 6.0 1 1 0.69 201 11
72 2 56 146 100 2 1 18.0 1 1 1.14 189 14
73 1 48 162 94 2 1 14.0 2 2 2.81 291 34
74 1 52 158 100 2 2 13.0 1 1 0.83 286 18
75 1 63 152 92 1 0 9 1 1 1.09 226 17
76 2 52 152 96 1 1 5.0 1 1 1.2 116 13
77 1 68 162 90 2 1 5.0 1 1 0.59 283 24
78 1 55 180 110 2 2 102 2 2 0.67 318 36
79 2 59 176 104 2 2 7200 2 2 0.54 296 39
80 1 51 146 96 1 0 8 1 1 1.3 242 14
81 1 65 178 76 2 1 6 2 2 0.37 320 36
82 2 50 160 90 2 0 7 1 1 1.5 215 20
83 2 50 172 100 2 1 13 1 1 1.2 240 25
84 1 54 150 92 1 1 5.0 1 1 1.3 250 26
85 1 46 148 92 1 0 14.0 1 1 1.4 156 12
86 2 47 160 100 2 1 6 1 1 0.92 260 25
87 1 50 150 86 1 0 8 1 1 1.7 240 25
88 1 66 160 104 2 2 152 2 2 0.6 313 14
89 2 48 152 90 2 1 14 1 1 1.5 215 28
90 1 45 170 100 2 2 56 2 2 0.86 286 16
91 1 44 142 116 2 1 12.0 1 1 0.9 214 39
92 2 40 154 90 1 0 5.0 1 1 1.4 232 22
93 1 60 150 100 2 1 9.0 1 1 1.3 180 16
94 1 62 174 84 2 1 14 1 1 1.4 222 32
95 2 72 200 100 2 2 48 2 2 0.9 291 38
96 2 45 172 100 2 0 16 1 1 1.8 150 24
97 1 54 188 108 2 1 12 1 1 1.9 200 30
98 1 35 142 96 1 0 10 2 2 1.62 186 22
99 2 54 146 116 2 1 24 2 2 0.6215 380 25
100 1 55 162 112 2 1 13 2 1 0.81 300 38
101 1 66 152 88 1 2 21 1 1 1.8 155 16
102 2 68 182 116 2 2 22 2 1 1.7 183 15
SL NO SEX AGE BP(SYS) BP(DIA) JNC RETINA ALBUMIN IVRT DT MITRAL E/A LV MASS RV6+SV1
103 1 62 198 130 2 2 82 2 2 0.84 299 38
104 1 72 168 108 2 2 200 2 2 0.53 400 39
105 1 62 164 90 2 1 126 2 2 0.76 340 10
106 2 55 172 110 2 0 12 1 1 1.9 110 28
107 2 60 162 94 2 0 8 1 1 1.4 162 24
108 1 62 178 100 2 1 23 1 1 1.8 164 16
109 1 74 144 90 1 0 19 2 2 0.82 288 25
110 1 54 166 100 2 1 16 2 2 0.96 276 24
111 2 54 180 130 2 1 7 1 1 1.9 220 20
112 2 54 174 92 2 0 5.0 1 1 2.4 154 20
113 1 68 186 100 2 2 19.0 2 2 0.91 268 25
114 2 74 172 72 2 1 14.0 2 2 24.0 280 38
115 1 56 142 90 1 0 9 1 1 0.78 152 13
116 2 50 144 86 1 2 32 2 2 24.0 260 17
117 2 66 166 90 2 2 14 2 2 26.01 268 37
118 1 46 170 100 2 1 8 1 1 17 125 25
119 1 50 152 88 1 1 2 2 1 16 215 20
120 2 56 208 110 2 1 2 2 2 35.0 286 27
121 1 68 160 90 2 0 14 2 2 0.84 312 28
122 1 74 164 74 2 0 7 1 1 1.93 194 32
123 1 50 160 100 2 1 6 2 2 0.59 408 38
124 2 52 158 112 2 2 2 2 2 0.88 248 15
125 2 54 180 142 2 1 42 2 2 0.94 310 16
126 1 74 164 74 2 0 7 1 1 1.82 194 28
127 1 52 156 102 2 1 12 2 2 0.78 400 27
128 2 51 158 110 2 2 29 2 1 1.43 206 16
129 2 52 186 148 2 1 112 2 2 0.92 311 18
130 2 54 166 100 2 2 52 1 1 0.85 278 38
131 1 52 176 90 2 2 19.0 2 2 0.87 327 36
132 1 60 176 94 2 2 18.0 2 2 0.97 276 38
133 1 52 180 88 2 1 34 2 2 0.94 286 29
134 1 54 154 96 1 1 18 2 2 0.83 288 20
135 1 60 194 98 2 3 200 2 2 0.79 350 21
136 1 64 182 80 2 1 11 2 2 1.9 194 20
137 2 64 176 100 2 2 14 1 1 0.93 208 20
SL NO SEX AGE BP(SYS) BP(DIA) JNC RETINA ALBUMIN IVRT DT MITRAL E/A LV MASS RV6+SV1
138 2 57 152 100 1 2 28 1 1 0.98 213 22
139 2 43 166 92 2 0 11 1 1 1.7 122 13
140 1 52 162 98 2 1 9 1 1 1.68 230 20
141 2 52 164 110 2 0 5.0 1 1 1.4 196 22
142 1 42 142 102 2 1 14.0 2 2 0.83 310 26
143 2 62 182 88 2 1 38 2 2 0.89 286 26
144 2 50 150 100 1 0 3 2 2 0.94 366 16
145 1 68 150 88 1 1 19.0 2 2 0.78 284 19
146 1 57 166 102 2 0 14 2 2 0.93 284 17
147 1 54 158 98 1 0 11 1 1 1.9 210 12
SL NO EF EDU INCOME
HEALTH SEEKING 
BEHAVIOUR GIDDINESS BREATHLESSNESS CHEST PAIN HEADACHE
1 1 12 5000 1 0 1 0 0
2 1 0 2000 1 0 0 0 0
3 1 12 3000 1 1 0 0 0
4 1 0 1000 1 0 0 0 0
5 1 5 1500 1 0 0 0 1
6 1 5 1500 2 1 0 0 1
7 1 5 1300 1 1 0 1 1
8 1 1 800 1 0 1 0 0
9 1 6 1000 1 1 0 0 0
10 1 4 1000 1 0 0 0 0
11 1 7 1500 1 1 0 0 0
12 1 0 600 1 0 1 1 0
13 1 10 1300 1 1 0 0 0
14 1 0 1000 2 1 0 0 0
15 1 0 600 1 1 1 1 0
16 1 6 1600 1 0 0 0 0
17 1 0 600 1 1 0 0 0
18 1 0 600 2 1 0 0 0
19 1 0 500 1 1 0 0 0
20 1 3 5000 1 1 0 1 0
21 1 5 2600 1 1 0 0 0
22 1 3 3000 1 1 0 0 1
23 1 0 1800 1 1 0 0 0
24 1 0 3000 2 0 1 0 0
25 1 8 3000 1 1 0 0 0
26 1 0 1000 1 1 0 0 1
27 1 3 750 1 0 0 1 0
28 1 0 1500 1 1 0 1 0
29 1 5 800 1 1 1 1 1
30 1 5 1500 1 0 1 1 0
31 1 0 1500 1 0 0 1 0
32 1 3 600 1 1 1 1 0
SL NO EF EDU INCOME
HEALTH SEEKING 
BEHAVIOUR GIDDINESS BREATHLESSNESS CHEST PAIN HEADACHE
33 1 12 9900 1 0 0 1 1
34 1 5 4000 2 0 0 0 1
35 1 2 600 1 0 0 0 0
36 1 7 1000 1 0 0 0 0
37 1 5 600 1 0 0 0 0
38 1 0 600 1 1 0 0 1
39 1 0 1000 1 1 0 0 1
40 1 0 1000 1 0 0 0 0
41 1 0 600 1 0 0 0 0
42 1 5 900 1 0 0 0 0
43 1 0 3000 1 0 1 0 0
44 1 5 1000 1 1 1 0 0
45 1 0 2000 1 0 0 0 1
46 1 5 2000 1 0 1 0 0
47 1 8 2000 1 1 0 1 0
48 1 4 4000 1 1 0 0 0
49 1 0 800 1 1 0 0 0
50 1 5 1200 2 0 0 1 0
51 1 0 500 1 0 0 1 0
52 1 9 1800 1 1 0 0 0
53 1 5 1500 1 1 0 0 0
54 1 4 900 1 1 1 1 0
55 1 3 600 1 1 0 0 0
56 1 0 2000 1 0 0 1 0
57 1 5 1000 1 0 0 1 0
58 1 15 2000 1 0 1 0 0
59 1 0 1500 1 1 0 1 0
60 1 8 1200 1 1 0 0 0
61 1 6 2000 1 0 1 0 0
62 1 7 2000 1 1 0 0 0
63 1 3 1000 1 1 0 0 0
64 1 8 1000 1 1 0 0 0
65 1 9 3000 1 1 0 0 0
66 1 5 700 1 1 0 0 0
67 1 8 2225 1 0 0 0 0
SL NO EF EDU INCOME
HEALTH SEEKING 
BEHAVIOUR GIDDINESS BREATHLESSNESS CHEST PAIN HEADACHE
68 1 6 1000 1 0 1 1 0
69 1 12 2400 2 1 0 1 0
70 1 8 1200 1 0 0 0 1
71 1 10 2800 1 1 0 0 0
72 1 3 800 1 0 0 0 1
73 1 5 3000 1 0 0 0 0
74 1 2 1500 1 0 1 0 0
75 1 0 900 2 0 0 1 1
76 1 0 800 1 0 1 0 0
77 1 3 800 1 0 1 1 0
78 1 5 6000 1 1 0 1 0
79 1 4 900 1 1 0 0 1
80 1 9 2600 1 1 1 0 1
81 1 4 5000 1 1 0 1 0
82 1 10 2000 1 1 0 0 1
83 1 5 1500 1 1 1 0 0
84 1 8 3000 1 0 0 0 0
85 1 11 3200 1 0 0 0 1
86 1 8 1000 1 1 0 0 0
87 1 10 2000 1 1 0 0 0
88 1 0 800 2 0 0 1 0
89 1 7 1500 1 1 1 0 0
90 1 5 1000 1 0 0 0 0
91 1 6 1600 2 0 1 0 0
92 1 4 600 1 0 0 1 1
93 1 8 2000 1 1 0 1 0
94 1 3 600 1 1 1 0 0
95 1 0 500 1 1 1 1 1
96 1 5 1500 1 1 0 0 1
97 1 2 600 1 0 1 1 0
98 1 10 1600 1 1 0 0 0
99 52 2 600 1 1 1 1 0
100 1 4 1000 1 1 1 0 0
101 1 5 1000 1 0 0 0 0
102 1 0 600 1 1 0 0 1
SL NO EF EDU INCOME
HEALTH SEEKING 
BEHAVIOUR GIDDINESS BREATHLESSNESS CHEST PAIN HEADACHE
103 1 2 600 2 1 1 1 0
104 1 6 800 1 1 0 0 1
105 1 3 800 1 1 0 1 1
106 1 6 2000 1 1 0 0 0
107 1 0 1800 1 0 0 1 0
108 1 4 2600 1 0 1 1 0
109 1 0 1600 1 1 0 0 0
110 1 2 800 2 0 1 0 0
111 1 9 3000 1 1 0 1 0
112 1 6 1000 1 1 0 0 1
113 1 3 850 1 0 0 1 0
114 1 7 1200 1 1 0 1 0
115 1 5 750 1 1 1 1 1
116 1 4 1300 1 0 1 1 0
117 1 0 800 1 0 0 1 0
118 1 3 600 1 1 1 1 0
119 1 11 8000 1 0 0 1 1
120 1 2 1750 2 1 0 0 1
121 1 2 600 1 0 0 0 0
122 1 0 450 1 0 0 1 0
123 1 3 600 1 1 1 0 0
124 1 0 600 1 1 1 0 1
125 1 2 300 1 1 1 1 1
126 1 6 1000 1 0 0 0 0
127 1 4 650 1 1 1 0 1
128 1 0 1450 1 1 1 0 0
129 1 2 1500 1 1 1 0 0
130 1 3 1250 1 1 0 1 0
131 1 5 850 1 0 0 0 0
132 1 8 2200 1 1 0 1 0
133 1 8 2000 1 1 0 0 0
134 1 3 1000 1 1 1 0 0
135 1 6 1500 1 1 0 0 0
136 1 1 500 1 0 1 1 0
137 1 5 900 1 1 0 0 1
SL NO EF EDU INCOME
HEALTH SEEKING 
BEHAVIOUR GIDDINESS BREATHLESSNESS CHEST PAIN HEADACHE
138 1 2 2000 1 0 1 1 0
139 1 5 1200 1 1 1 0 1
140 1 1 600 1 0 0 0 1
141 1 5 1800 1 0 1 0 0
142 1 8 2600 1 1 0 1 0
143 1 4 600 1 1 0 0 0
144 1 0 800 1 1 1 0 0
145 1 5 1300 2 0 0 1 0
146 1 7 2200 1 0 1 0 0
147 1 8 3100 1 0 0 0 1
EF- Ejection Fraction
Giddi - Giddiness Edu - Education 
Breath - Breathlessness HSB - Health Seeking behaviour
Chest - Chest discomfort 
Head - Headache 
IVRT HSB 
2- Native Medicine 
DT 1- Normal 
2- Abnormal Symptomology
1- Presence of symptom
0-No symptom 
BP (SYS) - Blood Pressure (Systolic) BP (DIA) - Blood Pressure (Diastolic)
JNC - Joint National Committee VII Classification 
1- Male 1- Normal 1- Allopathy
2 - Female 2- Abnormal 
Table 13: Age and Gender based classification of Retinopathy 
Age Group (in years) 
No. of Patients 
<45 45-65 >65 
Male Female Total 
Retinopathy 
Grade 
Male Female Male Female Male Female 
21 
(46.7%) 
24 
(53.3%) 
45 
(30.6%) 
0 
3  
(27.3%) 
9 
(69.2%) 
9 
(19.1%) 
15 
(31.9%) 
9 
(42.9%) 
0 
39 
(63.9%) 
22 
(36.1%) 
61 
(41.5%) 
I 
5 
(45.5%) 
1 
(7.7%) 
28 
(59.6%) 
20 
(42.6%) 
6 
(28.6%) 
1 
(12.5%) 
19 
(46.3%) 
22 
(53.7%) 
41 
(27.9%) 
II & III 
3 
(27.3%) 
2 
(13.63%) 
10 
(21.3%) 
12 
(54.55%) 
6 
(28.6%) 
7 
(31.82%) 
 
In the age group part of the table the percentage is divided in such a way that the total of all males and female 
are made upto 100%. 
 
Fig 6: Mean systolic blood pressure 
with age and gender 
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Fig 7: Diastolic blood pressure 
with age group and gender
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Fig 8: Categorization of Patients as per age and 
gender according to JNC VII
4
7
4
9
12
35
10
37
6
15
1
7
0
5
10
15
20
25
30
35
40
Grade I Grade II Grade I Grade II
Gender/JNC stage
No
.
 
o
f p
a
tie
n
ts
<45
45-65
>65
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
2
8
16
3
8
14
0
2
4
6
8
10
12
14
16
N
o
.
 
o
f p
a
tie
n
ts
Grade 0 Grade I Grade II & III
Retinopathy Grade
Fig 9: Pattern of Retinal involvement in 
patients with microalbuminuria 
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Fig 10: Pattern of Target organ damage in the 
Male study population
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Fig 11: Pattern of Target organ damage 
in the Female study population
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